Mizuho raises target price on Insmed to $158 from $154
INSM•Mizuho raised its target price on Insmed to $158 from $154.
Related News
NextEra, Dominion accept most Virginia merger conditions
NEE•
Fiserv gains after Q3 results beat estimates
FISV•
Ascentage Pharma announces participation in UBS, Jefferies investor conferences
AAPG•
Rexford Industrial Realty target price raised to $42 from $39
REXR•
BridgeBio to present new acoramidis data on heart failure events at AHA meeting
BBIO•